Half-year review of the Sartorius Stedim Biotech liquidity contract

Sartorius Stedim Biotech has published its half-year report for the liquidity contract managed by Kepler Cheuvreux as of June 30, 2026. At that date, the liquidity account held 38,829 shares and a cash balance of €6,040,068.12. During this period, 5,718 purchase transactions were executed, representing a volume of 342,335 shares and a total amount of €60,345,559.44. Sale transactions totaled 5,179, representing 336,472 shares for a total of €59,875,054.42.

For comparison, the previous balance sheet as of December 31, 2025, showed 32,966 shares and €6,457,086.94. The trading volume comprised 272,457 shares purchased for €51,769,936.60 and 275,047 shares sold for €52,809,559.69. Initially, the liquidity account held no shares but had €10,000,000 in cash. This balance sheet complies with AMF decision no. 2021-01 of June 22, 2021.